The strong Q3 results and record Q3 revenue/EBITDA confirm sustained box office recovery and market share gains. With $556M cash and net leverage at 2.0x, the balance sheet is healthy. Monitor the Q4 film slate and full-year capex guidance of ~$250M for signs of continued momentum.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 3 $38.51entry
- T+1 · 13d ago +4.86%α +3.20% · $40.38
- T+5 · 7d ago +6.93%α +7.52% · $41.18
- T+9 · todayOpen
- T+20 · in 15d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Cinemark reported Q3 2026 revenue of $1.06B, up 23.5% YoY, and GAAP diluted EPS of $1.04, up from $0.40 a year ago. Net income grew 146% YoY to $123M. The results beat consensus estimates of $0.95 EPS and $1.03B revenue, driven by record Q3 revenue and Adjusted EBITDA of $268M with margin expanding 460 bps YoY.
Key Financial Metrics
Key Facts
- Q3 2026 total revenue of $1,059.1M, up 23.5% YoY from $857.5M
- GAAP diluted EPS of $1.04 vs $0.40 in Q3 2025
- Net income attributable to Cinemark of $122.8M, up 146% YoY from $49.5M
- Adjusted EBITDA of $267.6M, up 50.7% YoY from $177.6M
- Adjusted EBITDA margin of 25.3%, expanding 460 bps YoY
- Record Q3 concession revenue per patron of $6.50
- Cash from operations of $136M and free cash flow of $66M in Q3
- Cash balance of $555.5M at quarter end, up from $344.3M at Dec 2025
- EPS of $1.04 beat consensus estimate of $0.95
- Revenue of $1.06B beat consensus estimate of $1.03B
Financial Impact
Revenue beat consensus by ~$29M (2.8%); EPS beat consensus by $0.09 (9.5%); net income more than doubled YoY
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| U.S. | $817.5M | +19.6% |
| International | $241.6M | +38.9% |
Risk Factors
- Box office performance depends on film slate quality and release timing, which is inherently lumpy
- Currency fluctuations in Latin American operations could impact reported results
- Rising operating costs (salaries, utilities) may pressure margins if revenue growth slows
- Full-year capex of ~$250M represents elevated investment spending
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-444332 |
| Document: cnk-20261103.htm | 0001193125-26-444332 |
| Document: 0001193125-26-444332-index-headers.html | 0001193125-26-444332 |
| Document: 0001193125-26-444332-index.html | 0001193125-26-444332 |
| Document: 0001193125-26-444332.txt | 0001193125-26-444332 |
| 8-K Data (Synthetic) | 0001193125-26-444332 |
Track record
8 reports on CNK
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today Institutional Cluster Mixed 3/10 Entry $40.32 Now $40.60 +0.69% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $40.35 Now $40.60 +0.63% settles Nov 23
- Nov 13, 20263d ago 8-K Neutral 2/10 Entry $41.18 Now $40.60 −1.41% settles Nov 23
- Nov 3, 202613d ago 8-K Bullish 6/10 Viewing Entry $38.51 to $41.18 Now $40.60 +5.43% ▲ +6.93% +7.52% vs SPY
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $38.51 to $41.18 Now $40.60 +5.43% ▲ +6.93% +7.52% vs SPY
- Jul 30, 202615w ago 8-K Bullish 8/10 Entry $36.15 to $37.95 Now $40.60 +12.31% ▲ +4.98% +1.36% vs SPY
- Jun 9, 202622w ago 144 Neutral 3/10 Entry $33.05 to $33.02 Now $40.60 +22.84% ▼ −0.09% −3.52% vs SPY
- Apr 1, 202632w ago DEFA14A Neutral 3/10 Entry $29.24 to $30.37 Now $40.60 +38.85% ▲ +3.86% +0.25% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers